Development of a high-throughput screening assay for cytoprotective agents in rotenone-induced cell death.

Parkinson's disease (PD) is a neurodegenerative disease featured by selective loss of substantia nigra neurons. Rotenone administration in animals induces neurodegeneration accompanied by α-synuclein-positive Lewy body-like inclusions, recapturing typical histopathological features of PD. In an effort to screen for small-molecule agents to reverse rotenone-induced cytotoxicity, we developed and validated a sensitive and robust assay with neuroblastoma SK-N-SH cells. This assay was amenable to a high-throughput screening format with Z' factor of 0.56. Robotic screening of a bioactive compound library led to the identification of carnosic acid that can effectively protect cells from rotenone treatment. Using a high-content image-based assay and Western blot analysis, we demonstrated that carnosic acid protects cells from rotenone stress by significant induction of HSP70 expression. Therefore, the assay reported here can be used to identify novel cytoprotective agents for clinical therapeutics of PD.

[1]  Bin Zhang,et al.  High-Content Image-Based Screening for Small-Molecule Chaperone Amplifiers in Heat Shock , 2008, Journal of biomolecular screening.

[2]  E. Kandel,et al.  Is Heterosynaptic modulation essential for stabilizing hebbian plasiticity and memory , 2000, Nature Reviews Neuroscience.

[3]  S. Ng,et al.  Pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione derivatives as novel small molecule chaperone amplifiers. , 2009, Bioorganic & medicinal chemistry letters.

[4]  Y. Takikawa,et al.  Carnosic acid and carnosol inhibit adipocyte differentiation in mouse 3T3-L1 cells through induction of phase2 enzymes and activation of glutathione metabolism. , 2009, Biochemical and biophysical research communications.

[5]  Jochen Klucken,et al.  Hsp70 Reduces α-Synuclein Aggregation and Toxicity* , 2004, Journal of Biological Chemistry.

[6]  T. Idziorek,et al.  YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability. , 1995, Journal of immunological methods.

[7]  Todd B. Sherer,et al.  Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein Aggregation , 2003, Experimental Neurology.

[8]  J. Cano,et al.  Mitochondrial toxins and neurodegenerative diseases. , 2007, Frontiers in bioscience : a journal and virtual library.

[9]  M. Brimble,et al.  A review of neuroprotective agents. , 2004, Current medicinal chemistry.

[10]  N. Wood,et al.  Understanding the molecular causes of Parkinson's disease. , 2006, Trends in molecular medicine.

[11]  D. Ethell,et al.  Parkinson-linked genes and toxins that affect neuronal cell death through the Bcl-2 family. , 2009, Antioxidants & redox signaling.

[12]  Howard E Gendelman,et al.  Oxidative stress and the pathogenesis of neurodegenerative disorders. , 2007, International review of neurobiology.

[13]  Z. Xia,et al.  Basic Fibroblast Growth Factor Protects against Rotenone-Induced Dopaminergic Cell Death through Activation of Extracellular Signal-Regulated Kinases 1/2 and Phosphatidylinositol-3 Kinase Pathways , 2006, The Journal of Neuroscience.

[14]  V. Uversky,et al.  Pesticides directly accelerate the rate of α‐synuclein fibril formation: a possible factor in Parkinson's disease , 2001, FEBS letters.

[15]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[16]  J. Langston,et al.  Increased striatal dopamine turnover following acute administration of rotenone to mice , 2000, Brain Research.

[17]  P. Muchowski,et al.  Modulation of neurodegeneration by molecular chaperones , 2005, Nature Reviews Neuroscience.

[18]  N. Wood,et al.  Expanding insights of mitochondrial dysfunction in Parkinson's disease , 2006, Nature Reviews Neuroscience.

[19]  Jiankun Cui,et al.  Carnosic acid, a catechol‐type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S‐alkylation of targeted cysteines on Keap1 , 2008, Journal of neurochemistry.

[20]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[21]  K. Manova,et al.  Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma. , 2008, Blood.

[22]  P. Muchowski.  Protein Misfolding, Amyloid Formation, and Neurodegeneration A Critical Role for Molecular Chaperones? , 2002, Neuron.

[23]  M. Fennell,et al.  Multiparameter Measurement of Caspase 3 Activation and Apoptotic Cell Death in NT2 Neuronal Precursor Cells Using High-Content Analysis , 2006, Journal of biomolecular screening.

[24]  W. Tatton,et al.  Etiology and pathogenesis of Parkinson's disease. , 1999, Annual review of neuroscience.

[25]  Todd B. Sherer,et al.  An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered α-Synuclein Metabolism and Oxidative Damage , 2002, The Journal of Neuroscience.

[26]  S. Shin,et al.  Formation and Removal of α-Synuclein Aggregates in Cells Exposed to Mitochondrial Inhibitors* , 2002, The Journal of Biological Chemistry.

[27]  Yan Leng,et al.  Prostaglandin A1 inhibits rotenone‐induced apoptosis in SH‐SY5Y cells , 2002, Journal of neurochemistry.

[28]  K. Heidenreich,et al.  The pesticide rotenone induces caspase‐3‐mediated apoptosis in ventral mesencephalic dopaminergic neurons , 2003, Journal of neurochemistry.

[29]  John Q. Trojanowski,et al.  Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease , 2001, Science.

[30]  D B Clarke,et al.  The role of heat shock proteins Hsp70 and Hsp27 in cellular protection of the central nervous system , 2005, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.